GSK licenses companies to make cheap copies of HIV prevention drug
By Maggie Fick LONDON (Reuters) -British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in lower-income countries, where the majority of new cases occur. The injected drug cabotegravir was approved by regulators in the United States in late 2021. Last …
GSK licenses companies to make cheap copies of HIV prevention drug Read More »










